HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh.

Abstract
Inter-individual genetic makeup can trigger variability in platinum-based chemotherapeutic responses and corresponding adverse drug reactions and toxicities. Exploring the genetic causes behind these inter-individual variabilities in platinum-based chemotherapeutic responses by investigating the effects of GSTP1 (rs1695), XRCC1 (rs25487), XPC (rs2228001) and ERCC1 (rs11615) genetic polymorphisms on toxicity and therapeutic response of this treatment among Bangladeshi advanced non-small cell lung cancer (NSCLC) patients was the aim of this study. 285 Clinically proven either stage IIIB or IV (advanced) NSCLC patients aging not less than 18 years old and receiving platinum-based chemotherapy were recruited to assess the influence of these four single nucleotide polymorphisms (SNPs) on peripheral leukocytes. Toxicity and response were evaluated by multivariate regression analyses using SPSS statistical software (version 17.0). XRCC1 (rs25487) polymorphism was found to act as a predictive factor for not only grade 3 and 4 anemia (p = 0.008), neutropenia (p = 0.010), thrombocytopenia (p = 0.025) and gastrointestinal toxicity (p = 0.002) but also for therapeutic response (p = 0.012) in platinum-based chemotherapy. Although GSTP1 (rs1695) polymorphism might serve as prognostic factor regarding grade 3 or 4 neutropenia, a significant (p = 0.044) improvement in response to platinum-based chemotherapy was observed. However, XPC (rs2228001) and ERCC1 (rs11615) polymorphisms could not establish any significant relation with toxicity or therapeutic response. XRCC1 (rs2228001) and GSTP1 (rs1695) polymorphisms might explain platinum-induced clinical outcomes in terms of both toxicity and therapeutic response variations among Bangladeshi advanced NSCLC patients.
AuthorsMost Umme Bushra, Sanzana Fareen Rivu, Ali Ehsan Sifat, Noor Ahmed Nahid, Maizbha Uddin Ahmed, Mir Md Abdullah Al-Mamun, Mohd Nazmul Hasan Apu, Md Siddiqul Islam, Md Reazul Islam, Mohammad Safiqul Islam, Abul Hasnat
JournalMolecular biology reports (Mol Biol Rep) Vol. 47 Issue 9 Pg. 7073-7082 (Sep 2020) ISSN: 1573-4978 [Electronic] Netherlands
PMID32880833 (Publication Type: Journal Article)
Chemical References
  • DNA-Binding Proteins
  • Neoplasm Proteins
  • X-ray Repair Cross Complementing Protein 1
  • XRCC1 protein, human
  • XPC protein, human
  • Platinum
  • GSTP1 protein, human
  • Glutathione S-Transferase pi
  • ERCC1 protein, human
  • Endonucleases
Topics
  • Bangladesh
  • Carcinoma, Non-Small-Cell Lung (drug therapy, genetics, pathology)
  • DNA-Binding Proteins (genetics)
  • Endonucleases (genetics)
  • Female
  • Glutathione S-Transferase pi (genetics)
  • Humans
  • Lung Neoplasms (drug therapy, genetics, pathology)
  • Male
  • Middle Aged
  • Neoplasm Proteins (genetics)
  • Platinum (administration & dosage, adverse effects)
  • Polymorphism, Single Nucleotide
  • Predictive Value of Tests
  • X-ray Repair Cross Complementing Protein 1 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: